Coronavirus disease 2019 and flight safety

Código QR

Coronavirus disease 2019 and flight safety

Guardado en:

Detalles Bibliográficos
Autor principal:	Sevgi Özcan
Formato:	article
Lenguaje:	EN
Publicado:	KARE Publishing 2021
Materias:	Diseases of the circulatory (Cardiovascular) system RC666-701
Acceso en línea:	https://doaj.org/article/72359d28f4454c31b4ceea480e2779ae
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Flight safety in patients with arrhythmia
por: Fahrettin Katkat
Publicado: (2021)

Coronavirus Disease 2019 and Cardiac Arrhythmias
por: Antoni Martínez-Rubio, et al.
Publicado: (2020)

Electrophysiology in the Era of Coronavirus Disease 2019
Publicado: (2020)

Coronavirus Disease 2019: Where are we and Where are we Going? Intersections Between Coronavirus Disease 2019 and the Heart
por: Emilia D’Elia, et al.
Publicado: (2020)

Coronavirus Disease 2019: Psychological Stress and Cardiovascular Diseases
por: Maki Komiyama, et al.
Publicado: (2021)

Treatment of Coronavirus Disease 2019: Shooting in the Dark
por: Juan Tamargo
Publicado: (2020)

Mechanisms of Myocardial Injury in Coronavirus Disease 2019
por: Aniket S Rali, et al.
Publicado: (2020)

The Renin–Angiotensin–Aldosterone System and Coronavirus Disease 2019
por: Eliecer Coto, et al.
Publicado: (2021)

Acute myocarditis after coronavirus disease 2019 vaccination
por: Beuy Joob, et al.
Publicado: (2021)

Colchicine, fragmented QRS, coronavirus disease 2019, and more
por: Çetin Erol
Publicado: (2021)

Coronavirus Disease 2019 Myocarditis: Insights into Pathophysiology and Management
por: Mahmoud Abdelnabi, et al.
Publicado: (2020)

Myocardial and Microvascular Injury Due to Coronavirus Disease 2019
por: Rocco A Montone, et al.
Publicado: (2020)

Coronavirus Disease 2019 and Heart Failure: A Multiparametric Approach
por: Estefania Oliveros, et al.
Publicado: (2020)

Acute Heart Failure in Coronavirus Disease 2019 and the Management of Comedications
por: Chia Siang Kow, et al.
Publicado: (2020)

Coronavirus Disease 2019 and Catheterisation Laboratory Considerations: “Looking for Essentials”
por: Syed Haseeb Raza Naqvi, et al.
Publicado: (2020)

Coronavirus Disease 2019: Cardiac Complications and Considerations for Returning to Sports Participation
por: Daniel X Augustine, et al.
Publicado: (2021)

The Coronavirus Disease 2019 Outbreak Highlights the Importance of Sex-sensitive Medicine
por: Angela HEM Maas, et al.
Publicado: (2020)

Cardiopulmonary Ultrasonography for Severe Coronavirus Disease 2019 Patients in Prone Position
por: Aniket S Rali, et al.
Publicado: (2020)

Door-to-balloon Time for ST-elevation MI in the Coronavirus Disease 2019 Era
por: Haytham Mously, et al.
Publicado: (2021)

Cardiovascular Clinical Trials in a Pandemic: Immediate Implications of Coronavirus Disease 2019
por: Ernest Spitzer, et al.
Publicado: (2020)

Anticoagulant Therapy for Patients with Coronavirus Disease 2019: Urgent Need for Enhanced Awareness
por: Maki Komiyama, et al.
Publicado: (2020)

Smoking Cessation as a Public Health Measure to Limit the Coronavirus Disease 2019 Pandemic
por: Maki Komiyama, et al.
Publicado: (2020)

Dilated Cardiomyopathy Risk in Patients with Coronavirus Disease 2019: How to Identify and Characterise it Early?
por: Maki Komiyama, et al.
Publicado: (2020)

Flight and diabetes
por: Mehmet Uğurlu
Publicado: (2021)

Cardiovascular Medical Education During the Coronavirus Disease 2019 Pandemic: Challenges, Adaptations, and Considerations for the Future
por: Hilary Shapiro, et al.
Publicado: (2021)

Effect of triple antimicrobial therapy on electrocardiography parameters in patients with mild-to-moderate coronavirus disease 2019
por: Burcu Uğurlu Ilgın, et al.
Publicado: (2021)

Ethical Issues in Decision-making Regarding the Elderly Affected by Coronavirus Disease 2019: An Expert Opinion
por: David Martínez-Sellés, et al.
Publicado: (2020)

Remote Clinics and Investigations in Arrhythmia Services: What Have We Learnt During Coronavirus Disease 2019?
por: Shohreh Honarbakhsh, et al.
Publicado: (2021)

Smoking and Angiotensin-converting Enzyme Inhibitor/Angiotensin Receptor Blocker Cessation to Limit Coronavirus Disease 2019
por: Marco Rossato, et al.
Publicado: (2020)

Maximising Opportunities Post Coronavirus Disease 2019: Time to Embrace a New Era of Atrial Fibrillation Research
por: Pier D Lambiase
Publicado: (2021)

Systemic arterial hypertension and flight
por: Kaan Okyay
Publicado: (2021)

The Coronavirus Disease 2019 pandemic among adult congenital heart disease patients: Findings of a one-year multicentric, international study
por: Francisco Javier Ruperti Repilado, et al.
Publicado: (2021)

Response to the Comment ‘Smoking and Angiotensin-converting Enzyme Inhibitor/Angiotensin Receptor Blocker Cessation to Limit Coronavirus Disease 2019
por: Maki Komiyama, et al.
Publicado: (2020)

Extracorporeal Membrane Oxygenation in Coronavirus Disease 2019-associated Acute Respiratory Distress Syndrome: An initial US Experience at a High-volume Centre
por: Yang Yang, et al.
Publicado: (2020)

The secret enemy during a flight: Economy class syndrome
por: Cengiz Şabanoğlu
Publicado: (2021)

Very Long-term Safety and Effectiveness of Drug-Eluting or Bare-Metal Stents for Left Main Coronary Disease
por: Hanbit Park, MD, et al.
Publicado: (2021)

Unsolved issues of The Efficacy and Safety of Edoxaban
por: Leszek Drabik, et al.
Publicado: (2021)

What Cannot Be Missed: Important Publications on Electrophysiology in 2019
por: Andrew Grace, et al.
Publicado: (2020)

Levosimendan Efficacy and Safety: 20 years of SIMDAX in Clinical Use
por: Zoltán Papp, et al.
Publicado: (2020)

Management of Acute Coronary Syndromes During the Coronavirus Disease 2019 Pandemic: Deviations from Guidelines and Pragmatic Considerations for Patients and Healthcare Workers
por: Henry Seligman, et al.
Publicado: (2020)